EV/EBITDA
-0.40
-0.01-2.56%
Fri, 07 Mar 2025 21:07:49 GMT
Summary
- As of March 10, 2025, CTCX EV/EBITDA is -0.40, with a fall of -0.01 (-2.56%) during the most recent trading day.
- Over the past year, CTCX EV/EBITDA has increased by +4.06 (+91.03%).
- CTCX EV/EBITDA is now -25.00% below its all-time high of -0.32.
Performance
CTCX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CTCX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.6% | +1.6% | +1.5% |
| 1 m1 month | +32.2% | -32.5% | -30.5% |
| 3 m3 months | +14.9% | -15.3% | -14.2% |
| 6 m6 months | +31.0% | -57.4% | -59.7% |
| ytdytd | +31.0% | -31.4% | -29.5% |
| 1 y1 year | +91.0% | -94.4% | -93.3% |
| 5 y5 years | - | - | - |
CTCX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.6% | -0.67 | +40.3% | |
| 3 m | 3-month | -0.39 | -2.6% | -1.34 | +70.2% |
| 6 m | 6-month | -0.32 | -25.0% | -1.46 | +72.6% |
| 1 y | 1-year | -0.32 | -25.0% | -4.58 | +91.3% |
| 3 y | 3-year | -0.32 | -25.0% | -13.62 | +97.1% |
| 5 y | 5-year | -0.32 | -25.0% | -13.62 | +97.1% |
| alltime | all time | -0.32 | -25.0% | -13.62 | +97.1% |
Carmell Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.40(-31.0%) |
| Date | Value |
|---|---|
| 2024 | -0.58(-89.9%) |
| 2023 | -5.77 |
FAQ
- What is Carmell Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Carmell Therapeutics?
- What is CTCX EV/EBITDA year-to-date change?
- What is Carmell Therapeutics EV/EBITDA year-on-year change?
What is Carmell Therapeutics EV/EBITDA?
The current EV/EBITDA of CTCX is -0.40
What is the all time high EV/EBITDA for Carmell Therapeutics?
Carmell Therapeutics all-time high EV/EBITDA is -0.32
What is CTCX EV/EBITDA year-to-date change?
Carmell Therapeutics EV/EBITDA has changed by +0.18 (+31.03%) since the beginning of the year
What is Carmell Therapeutics EV/EBITDA year-on-year change?
Over the past year, CTCX EV/EBITDA has changed by +4.06 (+91.03%)